SCHEMBL8947876

SCHEMBL8947876

O=C1C=Cc2ccccc2/C1=N/O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.55
KMT2A Q03164 6/20 0.55
ALDH1A1 P00352 5/20 0.55
MAPT P10636 5/20 0.55
KDM4E B2RXH2 4/20 0.55
IDO1 P14902 3/20 0.55
HPGD P15428 3/20 0.55
ALOX15 P16050 3/20 0.55
HSD17B10 Q99714 3/20 0.55
RECQL P46063 3/20 0.55
PTPRC P08575 3/20 0.55
PKM P14618 2/20 0.55
THRB P10828 2/20 0.55
LMNA P02545 2/20 0.55
POLB P06746 2/20 0.55
BCHE P06276 1/20 0.55
PTPN1 P18031 1/20 0.55
ACHE P22303 1/20 0.55
CES1 P23141 1/20 0.55
PTPN22 Q9Y2R2 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10976626 1.00 MEN1 (0.55) MEN1KMT2AALDH1A1MAPTKDM4E
Methoxymethane SCHEMBL7913630 0.93 MEN1 (0.48) MEN1KMT2AALDH1A1MAPTKDM4E
Benzoic Acid SCHEMBL7913659 0.88 KMT2A (0.44) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL20760919 0.80 MEN1 (0.55) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL31228817 0.78 MEN1 (0.48) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL7915148 0.77 IDO1 (0.52) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL9817317 0.76 PTPRC (0.62) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL7913628 0.76 KDM4E (0.50) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL25878337 0.76 MEN1 (0.50) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL13881950 0.76 MEN1 (0.50) MEN1KMT2AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046104-B2 Security printing INOVINK LIMITED (GB) 2021-06-29 US disclosed
US-20200361228-A1 IMPROVEMENTS IN RELATION TO SECURITY PRINTING INOVINK LIMITED (GB) 2020-11-19 US disclosed
US-9504637-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-11-29 US disclosed
US-9504637-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-11-29 US disclosed
US-9358578-B2 Printing INOVINK LIMITED (GB) 2016-06-07 US disclosed
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2016-04-21 US disclosed
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2016-04-21 US disclosed
US-9248086-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-02-02 US disclosed
US-9248086-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-02-02 US disclosed
US-20150174026-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2015-06-25 US disclosed
US-8444715-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2013-05-21 US disclosed
US-8444715-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2013-05-21 US disclosed
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2012-11-01 US disclosed
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2012-11-01 US disclosed
US-8187340-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2012-05-29 US disclosed
US-8187340-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2012-05-29 US disclosed
WO-2011084803-A2 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2011-07-14 WO disclosed
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2011-06-30 US disclosed
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2011-06-30 US disclosed
US-20090212554-A1 PRINTING INOVINK LIMITED (GB) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 MEN1 3187/4885KMT2A 1622/4885ALDH1A1 192/4885
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 MEN1 3187/4885KMT2A 1622/4885ALDH1A1 192/4885
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 MEN1 3187/4885KMT2A 1622/4885ALDH1A1 192/4885
US-20150174026-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 MEN1 3187/4885KMT2A 1622/4885ALDH1A1 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.